¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"steroid rebound phenomenon"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • steroid-induced atrophy
    ½ºÅ×·ÎÀ̵åÀ¯¹ßÀ§Ãà
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • aqueous-influx phenomenon
    ¹æ¼öÀ¯ÀÔÇö»ó
  • adoption phenomenon
    ä¿ëÇö»ó
  • clasp-knife phenomenon
    Á¢´ÂÄ®Çö»ó
  • closing-in phenomenon
    Á¾°áÇö»ó
  • critical phenomenon
    ÀÓ°èÇö»ó
  • crowding phenomenon
    ¹ÐÁýÇö»ó
  • cytopathogenic phenomenon
    ¼¼Æ÷º¯¼ºÇö»ó
  • centralization phenomenon
    Áß½ÉÈ­Çö»ó
  • duplication phenomenon
    º¹Á¦Çö»ó
  • delay phenomenon
    Áö¿¬Çö»ó
  • dawn phenomenon
    »õº®Çö»ó, ¿©¸íÇö»ó
  • discontinuity phenomenon
    ºÒ¿¬¼ÓÇö»ó
  • dissociative phenomenon
    ÇØ¸®Çö»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • steroid hormone
    ½ºÅ×·ÎÀ̵åÈ£¸£¸ó
  • steroid
    ½ºÅ×·ÎÀ̵å
  • adoption phenomenon
    ä¿ëÇö»ó
  • aqueous-influx phenomenon
    ¹æ¼öÀ¯ÀÔÇö»ó
  • clasp-knife phenomenon
    Á¢´ÂÄ®Çö»ó
  • closing-in phenomenon
    Á¾°áÇö»ó
  • critical phenomenon
    ÀÓ°èÇö»ó
  • crowding phenomenon
    ¹ÐÁýÇö»ó
  • cytopathogenic phenomenon
    ¼¼Æ÷º¯¼ºÇö»ó
  • delay phenomenon
    Áö¿¬Çö»ó
  • discontinuity phenomenon
    ºÒ¿¬¼ÓÇö»ó
  • dissociative phenomenon
    ÇØ¸®Çö»ó
  • doll¡¯s head phenomenon
    ÀÎÇü¸Ó¸®Çö»ó
  • down phenomenon
    »õº®Çö»ó, ¿©¸íÇö»ó
  • duplication phenomenon
    º¹Á¦Çö»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Faraday s phenomenon
    ÆÐ·¯µ¥ÀÌÇö»ó.
  • Fowler phenomenon
    º¸ÃæÇö»ó
  • Gibbs phenomenon
    ±é½º Çö»ó
  • Gunns pupillary phenomenon
    °Ç¾¾µ¿°øÇö»ó
  • Hirsts phenomenon
    Ç㽺Ʈ Çö»ó
  • Jack-in-the-box phenomenon
    µ¹¿¬½ÃÇö»ó
  • Kanagawa hemolysis phenomenon
    Ä«³ª°¡¿Í ¿ëÇ÷Çö»ó (º´¿ø¼º ºñºê¸®¿ÀÀÇ)
  • Kochs phenomenon
    ÄÚÈ£Çö»ó
  • Koebner phenomenon
    Äêºê³Ê Çö»ó
  • LE cell phenomenon
    LE¼¼Æ÷Çö»ó.
  • Lusts phenomenon
    ·¯½ºÆ® Çö»ó.
  • Mizuos phenomenon
    ¹ÌÁî¿ÀÇö»ó
  • Pel-Ebstein phenomenon
    Æç-¿¦½´Å¸ÀÎ Çö»ó
  • Pfeiffers phenomenon
    ÆÄÀÌÆÛ ¿ë±ÕÇö»ó (ÄÝ·¹¶ó±ÕÀÇ)
  • Pulfrich phenomenon
    Ç®ÇÁ¸®È÷Çö»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • steroid
    ½ºÅ×·ÎÀ̵å.
  • steroid acne
    ½ºÅ×·ÎÀÌµå ¿©µå¸§
  • steroid anesthetic
    ½ºÅ×·ÎÀ̵帶ÃëÁ¦.
  • steroid cataract
    ½ºÅ×·ÎÀ̵å¹é³»Àå
  • steroid folliculitis
    ½ºÅ×·ÎÀÌµå ¸ð³¶¿°
  • steroid glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • steroid hormone
    ½ºÅ×·ÎÀ̵åÈ£¸£¸ó(ºÎ½ÅÇÇÁúÈ£¸£¸ó)((¡­Üùãìù«òõ¡­)
  • steroid myopathy
    ½ºÅ×·ÎÀ̵å±Ùº´Áõ(¡­Ü»ñø)
  • steroid psychosis
    ½ºÅ×·ÎÀ̵å Á¤½ÅÁõ(º´).
  • steroid purpura
    ½ºÅ×·ÎÀ̵å ÀÚ¹Ý
  • steroid sulfatase deficiency
    ½ºÅ×·ÎÀ̵弳ÆÄÅ×À̽º°áÇÌ(Áõ)(¡­ÌÀù¹(ñø))
  • steroid-induced atrophy
    ½ºÅ×·ÎÀ̵å À§Ãà
  • steroid-induced disorders
    ½ºÅ×·ÎÀ̵å À¯¹ßÀå¾Ö(º´).
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • steroid-related disorders
    ½ºÅ×·ÎÀÌµå °ü·ÃÀå¾Ö(º´).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • steroid number
    ½ºÅ×·ÎÀÌµå ¹øÈ£(ÛãûÜ)
  • steroid receptor
    ½ºÅ×·ÎÀÌµå ¼ö¿ëü (áôé»ô÷)
  • steroid saponin
    ½ºÅ×·ÎÀÌµå »çÆ÷´Ñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
VF   1) Ventricular Fibrillation
    ? Tx of Ventricular Fibrillation ...
B-G Bordet-Gengou [agar, bacillus, phenomenon]
CREST calcinosis, Raynaud phenomenon, esophageal involvement, sclerodactyly, and telangiectasia [syndrome]...
CRST calcinosis, Raynaud phenomenon, sclerodactyly, telangiectasia [syndrome]; corrected sinus recovery t...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AAS Anabolic androgenic steroid
NSAID Non Steroid Anti-Inflammatory Drugs
SBP Steroid Binding Protein
SRC-1 Steroid Receptor Coactivator-1
SR Steroid receptors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • central pain phenomenon
    ÁßÃß¼º µ¿Åë Çö»ó
  • Chiristensen phenomenon
    Å©¸®½ºÅÙ¼¾ Çö»ó
    ÇϾÇÀÇ Àü¹æ¿îµ¿ ½Ã ´ëÇÕÇÏ´Â ±³ÇÕ¸é »çÀÌ¿¡ »ý±â´Â °£°Ý.
  • Christensen's phenomenon
    Å©¸®½ºÅÙ¼¾ Çö»ó
  • Class Switching phenomenon
    ºÐ·ù Àüȯ Çö»ó
    ÇϳªÀÇ B ¼¼Æ÷°¡ ±×¿¡ »óÀÀÇÒ ¼ö Àִ ƯÀÌ Ç׿ø¿¡ Á¢ÇÏ¿´À» ¶§ isoty
  • dawn phenomenon
    »õº® Çö»ó
    Á¦ 1Çü ´ç´¢º´ ȯÀÚÀÇ 75%¿¡¼­, ±×¸®°í ´Ù¼öÀÇ Á¦ 2Çü ´ç´¢º´ ȯÀÚ ¹× Á¤»óÀο¡¼­µµ ÀϾ´Ù. À̰ÍÀº ¿ÀÀü 5-8½Ã »çÀÌ¿¡ Àν¶¸°¿¡ ´ëÇÑ Á¶Á÷ÀÇ °¨¼ö¼ºÀÌ °¨¼ÒÇÏ¿© ÀϾ´Ù. ÃÖ±ÙÀÇ Áõ°Å´Â ÀÌ Çö»óÀÌ ¼ö¸é Áß¿¡ ¼ºÀå È£¸£¸ó ºÐºñÀÇ Áõ°¡¿¡ ÀÇÇÏ¿© À¯¹ßµÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. »õº® Çö»óÀÌ ´Üµ¶À» ¹ß»ýÇϸé À̸¥ ¾ÆÄ§¿¡ °æµµÀÇ °íÇ÷´çÁõÀÌ ¿À³ª ¼Ò¸ð±â È¿°ú³ª °¨Åð Çö»óÀÌ µ¿¹ÝµÇ¸é °íÇ÷´çÁõÀº ½ÉÇØÁø´Ù.
  • dolls head phenomenon
    ÀÎÇü ¸Ó¸® Çö»ó, ÀÎÇü µÎ Çö»ó
  • flare phenomenon
    Àå°³ Çö»ó
  • Fowler phenomenon
    º¸Ãæ Çö»ó
  • iceberg phenomenon
    ºù»ê Çö»ó
  • jaw winking phenomenon
    ÅÎ-À®Å© Çö»ó
  • light absorption phenomenon
    ºû Èí¼ö Çö»ó
  • metallic phenomenon
    ±Ý¼Ó¼º Çö»ó
  • mucus extravasation phenomenon
    Á¡¾× À¯Ãâ Çö»ó
  • orbicularis phenomenon
    À±±Ù Çö»ó
  • phenomenon
    Çö»ó
    1. ¾î¶² ¡Èijª °´°üÀûÀÎ Áõ»ó. 2. ¾î¶² ÁÖ¸ñÇÒ¸¸ÇÑ »ç°Ç ¶Ç´Â »ç½Ç.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
steroid 19-hydroxylase <enzyme> Enzyme from adrenal mitochondria; forms 19-hydroxy-11-deoxycorticosterone
Registry number: EC 1.14.13.-
Synonym: 19-hydroxysteroid hydroxylase, deoxycorticosterone 11-19-hydroxylase
(26 Jun 1999)
steroid 21-monooxygenase <enzyme> A steroid hydroxylase system found in adrenal cortex microsomes. It catalyses the 21-hydroxylation of corticosteroids and shows a requirement for NADPH and molecular oxygen. Its deficiency is a cause of adrenogenital syndrome.
Chemical name: Steroid,hydrogen-donor:oxygen oxidoreductase (21-hydroxylating)
Registry number: EC 1.14.99.10
(12 Dec 1998)
steroid (23R)-hydroxylase <enzyme> Increased (23r)-hydroxylase activity in patients with cerebrotendinous xanthomatosis, an inborn error of metabolism in bile acid synthesis resulting in (23r)-hydroxylation of bile acids
Registry number: EC 1.14.99.-
Synonym: bile acid (23r)-hydroxylase, bile alcohol (23r)-hydroxylase
(26 Jun 1999)
steroid 25-hydroxylase <enzyme> Involved in cholesterol degradation to cholic acid
Registry number: EC 1.14.99.-
(26 Jun 1999)
steroid 5a-reductase <enzyme> An enzyme that uses NADPH to reduce certain steroids (e.g., the conversion of testosterone to dihydrotestosterone a deficiency of this enzyme is associated with a form of male pseudohermaphroditism in which genetic males have male genitals as well as female external genitalia.
(05 Mar 2000)
steroid 7 alpha-hydroxylase <enzyme> Testosterone and androstenedione incubated with microsomes from rat testes produced 7alpha-hydroxytestosterone and 7alpha-hydroxyandrostenedione
Registry number: EC 1.14.99.-
Synonym: testicular 7 alpha-hydroxylase, 7 alpha-hydroxylase, microsomal 7alpha-hydroxylase, andiostenedione 7 alpha-hydroxylase, sterol 7 alpha-hydroxylase, cytochrome p-450iia1, cytochrome p450iia1
(26 Jun 1999)
steroid 9 alpha monooxygenase <enzyme> Consists of an electron transport chain of NADH-dependent flavoprotein reductase and 2 iron-sulfur proteins; from nocardia
Registry number: EC 1.14.99.-
Synonym: steroid 9 alpha-hydroxylase
(26 Jun 1999)
steroid acne Folliculitis similar to acne vulgaris, but resulting from topical or oral administration of steroids; comedones are rare.
(05 Mar 2000)
steroid alpha-ketol oxidase <enzyme> In conjunction with corticosteroid side-chain-isomerase (EC 5.3.1.21) converts desoxycorticosterone to a 20-oxo-21-oic acid (pregnenoic acid)
Registry number: EC 1.2.1.-
(26 Jun 1999)
steroid delta-isomerase <enzyme> Pharmacological action: enzyme inhibitor
Registry number: EC 5.3.3.1
Synonym: delta 5-3-oxosteroid isomerase, delta-5-3-ketosteroid isomerase, 3-ketosteroid isomerase, 3-oxosteroid delta 4-5 isomerase, 5-ene-3-ketosteroid isomerase, 5-ene-4-ene-steroid isomerase, 3-oxo-delta(5)-steroid isomerase, 5-pregnene-3,20-dione isomerase, steroid 5-4-ene-isomerase, delta(5)-3-ketosteroid isomerase
(26 Jun 1999)
steroid diabetes Diabetes mellitus produced by pharmacological doses of steroid hormones, particularly glucocorticoids or oestrogens; characterised by one or more of the typical manifestations of diabetes mellitus.
(05 Mar 2000)
steroid fever Fever presumably caused by elevated plasma concentrations of certain pyrogenic steroids; can be produced by administration of etiocholanolone.
(05 Mar 2000)
steroid finger motif Family of nuclear transcription factors, most of which are receptors for hormones of the steroid family, for example androgen, oestrogen, glucocorticoid, mineralocorticoid, progesterone, retinoic acid, ecdysone, thyroid hormone and the Drosophila transcription factors knirps, ultraspiracle and seven up. This family contains a conserved domain (the steroid finger motif) containing two C4 type zinc fingers.
(18 Nov 1997)
steroid hormone <endocrinology> A group of structurally related hormones, based on the cholesterol molecule. They control sex and growth characteristics, are highly lipophilic and are unique in that their receptors are in the nucleus, rather than on the plasma membrane.
Examples: testosterone, oestrogen.
(18 Nov 1997)
steroid hormones Those hormone's possessing the steroid ring system; e.g., androgens, oestrogens, adrenocortical hormone's.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á